Data as of 4:00pm ET
| +0.65 / +0.82%|
The 23 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 100.00, with a high estimate of 132.00 and a low estimate of 82.00. The median estimate represents a +24.64% increase from the last price of 80.23.
The current consensus among 29 polled investment analysts is to Buy stock in Gilead Sciences Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.